Command Ultra II
by Cardiac Pacemakers, Inc. 2 variants
510(k) K831216
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK831216 | Date12 Jul 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Command Ultra II is an Implantable Pacemaker Pulse-Generator, designed to regulate heart rhythm by delivering electrical impulses to the heart muscle when necessary. This device is intended for patients with bradycardia or other cardiac conduction disorders requiring chronic pacing support.
This device is supplied as a single-use implantable component and is regulated under FDA 510(k) clearance (K831216) as a Class III medical device. It is intended for surgical implantation by qualified healthcare professionals in a sterile operating environment, with no noted MRI safety restrictions. The product code DXY classifies it under the regulatory category for implantable pacemaker pulse-generators.
Other devices from Cardiac Pacemakers, Inc.
Questions
AI-generated answers, 18 Sep 2026
What types of patients is the Command Ultra II designed to support, and how does it work?
The Command Ultra II is designed for patients with bradycardia or other cardiac conduction disorders that require chronic pacing support. It functions as an implantable pacemaker pulse-generator, delivering regulated electrical impulses to the heart muscle to maintain a proper heart rhythm when the natural conduction system fails.
Is the Command Ultra II intended for reuse, or is it a single-use device?
The Command Ultra II is explicitly supplied as a single-use implantable component. It is intended for one-time surgical implantation by qualified healthcare professionals and is not designed for reuse.
What regulatory pathway does the Command Ultra II follow, and what does that mean for its use?
The Command Ultra II is regulated under the FDA’s 510(k) clearance process (K831216) as a Class III medical device, meaning it has undergone a thorough review to demonstrate substantial equivalence to a predicate device. This clearance confirms it meets FDA safety and effectiveness standards for use as an implantable pacemaker pulse-generator in a sterile operating environment.
Are there any special considerations for storage or handling of the Command Ultra II before implantation?
While the provided data does not specify storage conditions, the Command Ultra II is an implantable device intended for surgical use in a sterile environment. It should be handled according to standard sterile medical device protocols to ensure patient safety and device integrity prior to implantation.